DOMINICI MASSIMO has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ZHEJIANG COMPVSS BIOTECHNOLOGY CO LTD, FORNIX BIOSCIENCES N V and CHIMERA BIOENGINEERING INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Italy | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Dominici Massimo | 19 |
#2 | Conte Pierfranco | 7 |
#3 | Paolucci Paolo | 6 |
#4 | Veronesi Elena | 6 |
#5 | Candini Olivia | 5 |
#6 | Grisendi Giulia | 4 |
#7 | Bussolari Rita | 4 |
#8 | Campana Dario | 3 |
#9 | Murgia Alba | 3 |
#10 | Spano Maria Carlotta | 3 |
Publication | Filing date | Title |
---|---|---|
EP3443074A1 | Method of analyzing the potential of mesenchymal stem/stromal cells in tissue regeneration | |
CN106574250A | Method for production of modified cells exprining HOX and modified cells obtained by the method | |
US2015320803A1 | Method for production of anti-tumor TRAIL protein | |
US2014302605A1 | Method of obtaining a population of cells | |
WO2013061273A1 | A modified effector cell (or chimeric receptor) for treating disialoganglioside gd2 -expressing neoplasia | |
US2013130381A1 | Method for obtaining a population of stromal progenitor cells | |
US2012100614A1 | Method for production of anti-tumor TRAIL protein |